Cargando…

Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDA) is characterized by an extremely poor prognosis. An inflammatory microenvironment triggers the pronounced desmoplasia, the selection of cancer stem-like cells (CSCs) and therapy resistance. The anti-inflammatory drug aspirin is suggested to lower the risk for P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yiyao, Liu, Li, Fan, Pei, Bauer, Nathalie, Gladkich, Jury, Ryschich, Eduard, Bazhin, Alexandr V., Giese, Nathalia A., Strobel, Oliver, Hackert, Thilo, Hinz, Ulf, Gross, Wolfgang, Fortunato, Franco, Herr, Ingrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496413/ https://www.ncbi.nlm.nih.gov/pubmed/25846752

Ejemplares similares

Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine
por: Isayev, Orkhan, et al.
Publicado: (2014)

Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication
por: Forster, Tobias, et al.
Publicado: (2014)

Intraductal papillary mucinous neoplasm of the pancreas rapidly xenografts in chicken eggs and predicts aggressiveness
por: Zhao, Zhefu, et al.
Publicado: (2017)

Effects of neoadjuvant FOLFIRINOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma
por: Xie, Li, et al.
Publicado: (2019)

The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer
por: Hage, C, et al.
Publicado: (2013)

The complexities of breast cancer desmoplasia
por: Walker, Rosemary A
Publicado: (2001)

Desmoplasia and Chemoresistance in Pancreatic Cancer
por: Schober, Marvin, et al.
Publicado: (2014)

Selective targeting of liver cancer with the endothelial marker CD146
por: Thomann, Stefan, et al.
Publicado: (2014)

Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1
por: Liu, Li, et al.
Publicado: (2017)

Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine
por: Lankadasari, Manendra Babu, et al.
Publicado: (2018)

Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells
por: LABSCH, SABRINA, et al.
Publicado: (2014)

Hypoxia Induces EMT in Low and Highly Aggressive Pancreatic Tumor Cells but Only Cells with Cancer Stem Cell Characteristics Acquire Pronounced Migratory Potential
por: Salnikov, Alexei V., et al.
Publicado: (2012)

Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy
por: Liu, Li, et al.
Publicado: (2022)

Desmoplasia in Pancreatic Cancer. Can We Fight It?
por: Merika, E. E., et al.
Publicado: (2012)

Overcoming chemoresistance in pancreatic cancer cells: role of the bitter taste receptor T2R10
por: Stern, Louisa, et al.
Publicado: (2018)

Granular cell ameloblastoma showing desmoplasia
por: Gupta, Suchitra, et al.
Publicado: (2012)

Collagen Organization Does Not Influence T-Cell Distribution in Stroma of Human Pancreatic Cancer
por: Kamionka, Eva-Maria, et al.
Publicado: (2021)

Targeting desmoplasia in pancreatic cancer as an essential first step to effective therapy
por: Ebelt, Nancy D., et al.
Publicado: (2020)

Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
por: Williamson, Tara, et al.
Publicado: (2021)

Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype
por: Wolf, Benjamin, et al.
Publicado: (2023)

Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression
por: Alam, Muhammad S., et al.
Publicado: (2015)

UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis
por: Luo, Yiqiao, et al.
Publicado: (2022)

Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer
por: Abukiwan, Alia, et al.
Publicado: (2018)

Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer
por: Abukiwan, Alia, et al.
Publicado: (2023)

HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study
por: Schott, Sarah, et al.
Publicado: (2017)

Distinct Origin of Claudin7 in Early Tumor Endosomes Affects Exosome Assembly
por: Kyuno, Daisuke, et al.
Publicado: (2019)

Conophylline suppresses pancreatic cancer desmoplasia and cancer‐promoting cytokines produced by cancer‐associated fibroblasts
por: Ishii, Norihiro, et al.
Publicado: (2018)

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
por: Creeden, Justin F., et al.
Publicado: (2020)

Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl
por: Nwaeburu, Clifford C., et al.
Publicado: (2016)

Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial
por: Lozanovski, Vladimir J, et al.
Publicado: (2014)

SST gene hypermethylation acts as a pan‐cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood‐based diagnosis
por: Manoochehri, Mehdi, et al.
Publicado: (2020)

Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages
por: Incio, Joao, et al.
Publicado: (2015)

Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression
por: Yang, Zongyuan, et al.
Publicado: (2017)

Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer
por: Throm, Verena M., et al.
Publicado: (2018)

Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients
por: Ahmed, Azaz, et al.
Publicado: (2023)

Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer
por: Yin, Libo, et al.
Publicado: (2019)

Autophagy in stromal fibroblasts promotes tumor desmoplasia and mammary tumorigenesis
por: Rudnick, Jenny A., et al.
Publicado: (2021)

Mitochondria and Cancer
por: Bazhin, Alexandr V.
Publicado: (2020)

Myofibroblastic CAF Density, Not Activated Stroma Index, Indicates Prognosis after Neoadjuvant Therapy of Pancreatic Carcinoma
por: Heger, Ulrike, et al.
Publicado: (2022)

A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation
por: Harryvan, T.J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7gftlavmt2ageer7k3bi1kuf4u